Daxor
DXR · NASDAQ
About DXR
- Employees
- 0
- Headquarters
- Oak Ridge, Tennessee
- Listed
- Jul 25, 1983
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- daxor.com
DXR key statistics
- Market cap
- 61.48M
- Price-earnings ratio
- 5.43
- Dividend yield
- —
- Average volume
- 15.52K
- Volume
- 2.84K
- Open price
- $9.80
- High today
- $10.04
- Low today
- $9.70
- 52 Week high
- $14.76
- 52 Week low
- $8.56
Daxor (DXR) at a glance
As of Oct 20, 2026, Daxor (DXR) shares are priced at $9.75, giving the company a market cap of 61.48M and a price-to-earnings ratio of 5.43.
Today the stock has traded between $9.70 and $10.04. The current price is 0.5% above the day's low and 2.9% below its high.
Volume so far is 2.84K shares, below the average of 15.52K shares a day.
Over the past year Daxor has ranged from $8.56 to $14.76, and now sits 19% of the way up that range.
Daxor met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q3 FY07 it reported $0.43 per share against an estimate of $0.101.
DXR earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 1321.8% on average.
- Q4 FY05: reported -$0.19 per share against an estimate of -$0.1111
- Q1 FY06: reported -$0.01 per share against an estimate of -$0.1111
- Q2 FY06: reported $0.03 per share against an estimate of -$0.0808
- Q3 FY06: reported -$0.20 per share against an estimate of -$0.0202
- Q4 FY06: reported $0.01 per share against an estimate of -$0.0202
- Q1 FY07: reported $0.66 per share against an estimate of -$0.0303
- Q2 FY07: reported $0.51 per share against an estimate of $0.0101
- Q3 FY07: reported $0.43 per share against an estimate of $0.101
DXR news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
- Press releaseGlobe Newswire
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
- Press releaseGlobe Newswire
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
- Press releaseGlobe Newswire
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
- Press releaseGlobe Newswire
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
- Press releaseGlobe Newswire
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
- Press releaseGlobe Newswire
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
Similar companies
Companies in the same industry as Daxor
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.